PTX
Click for more information
7.32% 4.4¢ prescient therapeutics limited

PTX chart, page-534

  1. Hodgie28
    601 Posts.
    lightbulb Created with Sketch. 839
    clock Created with Sketch.
    14/02/20
    18:43
    Post #: 42943339
    Agreed
    massive disconnect between market cap and clinical development.

    KRAS/RAS - comparison

    Revolution Medicines IPO - $US 238 million raised this week. Pipeline:-
    One candidate in phase 1 trial and 3 preclinical

    Prescient- Pipeline
    One candidate in phase 2 trial and three others in phase 1. Great data thus far.
    Market Cap - $AU 20 million.
    Go figure??
    PTX Price at posting: 5.3¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 16  Upvote
    lightbulb Created with Sketch. 2  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ENR Encounter Resources flags latest niobium hits in fresh assay data
right-arrow Created with Sketch.
HCH Hot Chili sets up water company as drought racks Chile–but must also build communities a desal plant
right-arrow Created with Sketch.
MGT Magnetite Mines set to progress DFS for Razorback through deal with JFE Shoji
right-arrow Created with Sketch.
CXO Core Lithium narrowly beats guidance on FY24 spodumene production but 1Y returns still shattered
right-arrow Created with Sketch.
PMT High-grade lithium zone extended at Patriot's Corvette project, drilling grades at 5%
right-arrow Created with Sketch.
NEWS Good debt vs bad debt for the property in your investment portfolio
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.4¢ 		Change
0.003(7.32%) 		Mkt cap ! $35.43M
Open High Low Value Volume
4.1¢ 4.4¢ 4.0¢ $20.95K 507.0K

Buyers (Bids)

No. Vol. Price($)
8 216927 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 238807 2
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.